Guideline on treating community-acquired pneumonia with Chinese patent medicines

• Ngā kaituhi matua: Minghang Wang (Author), Huiguo Liu (Author), Yaolong Chen (Author), Jiajie Yu (Author), Jiangtao Lin (Author), Zengtao Sun (Author), Jiansheng Li (Author), Gang Bai (Author), Fuqiang Wen (Author), Yang Xie (Author), Jianxin Wang (Author), Jiang Yang (Author), Suyun Li (Author)
• Hōputu: Pukapuka
• I whakaputaina: Elsevier, 2023-10-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Community-acquired pneumonia (CAP) is one of the most common infectious diseases, and its morbidity and mortality increase with age. Resistance and mutations development make the use of anti-infective therapy challenging. Chinese patent medicines (CPMs) are often used to treat CAP in China and well...